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ABSTRACT  
Objective: The objective of this work is to synthesize new molecules with biological characteristics against some infectious germs.  
Methods: The method of synthesis is based on the exploitation of the reactivity of the position-1 of the benzimidazole. It consisted of reacting the 
bis-benzimidazole 5 with the 1,2-dicloroethane in a solution of NaOH 2N (6,4%). The compound 6 is refluxed with ethanol with the different 
thioaryls to lead to compounds 7.  
Results: Thus, a series of molecules derived from bis-benzimidazoles were synthesized including N-alkylated 6 and 7a-d. The characterization of 
these newly synthesized compounds was performed by NMR (1H and 13C) and mass spectroscopy methods.  
Conclusion: The purified and characterized compounds 6 and 7a-d allow the development of a new chemical class of anti-infectives. 
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INTRODUCTION 
Benzimidazole, as a result of the replacement of the imidazole nucleus 
by other pentagonal heterocycles, notably thiazole and oxazole, leads 
respectively to the analogues benzothiazoles [1] and benzoxazoles [2]. 
Currently, the fight against certain infectious diseases is based on the 
use of molecules containing in their skeleton the benzothiazole rings 
and its analogues. We will mention among others: Riluzole used to 
treat amyotrophic lateral sclerosis [3], albendazole [4], used to 
eliminate gastrointestinal parasites, chlormidazole in therapeutics as 
the first antifungal [5-8] and Flunoxaprofen [9, 10] for the treatment of 
cancer (fig. 1). However, their therapeutic efficacy is becoming 
increasingly limited by the emergence of resistant microbial strains. In 
this context, it seems crucial to design and prepare new anti-infective 
agents with potentially better performance. In this perspective, we are 
interested in the chemical series of 2-thiomethylbenzimidazoles. The 
objective of this work is to develop new biomolecules likely to fight 




























Fig. 1: Commercial molecules against various infections 
 
MATERIALS AND METHODS 
The 1H proton (300-400 MHz) and 13C carbon (75-100 MHz) Nuclear 
Magnetic Resonance (NMR) spectra were recorded on a Brüker 
Advance 300, Tetramethylsilane (TMS) is used as an internal 
reference for chemical shifts expressed in ppm. Mass spectra (MS) 
were performed on an HP 5889A quadrupole electron impact (IE) or 
chemical ionization (CI) spectrometer. Melting points were 
determined by means of a KÖFFLER bench with temperature 
grading (40-260 °C). Dichloromethane, toluene, ethanol, ethyl 
acetate and hexane were distilled under atmospheric pressure. The 
purifications by column chromatography were carried out on silica 
gel type Kieselgel 60 (230-400 mesh-Merck). 
The aim of this work is to synthesize 2-thiomethylbenzimidazolyl-
benzothiazole derivatives substituted in position 1 of the pyrrolic 
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nitrogen. The methodology of the work consisted of condensing a 
chlorinating agent on heterocyclic and aryl compounds. To achieve these 
objectives, we initially performed the synthesis of 1-(chloroethyl)-2-
thiomethylbenzimidazolylbenzothiazole (6). The 2-
thiomethylbenzimidazolyl-benzothiazole (5) which served as our basic 
molecule was obtained in 54% yield by reacting 2-
mercaptobenzothiozole and 2-chloromethylbenzimidazole in a mixture 
of THF/NEt3 (triethylamine/tetrahydrofuran) at room temperature. 
Then, 1,2-dicloroethane reacted with 2-thiomethyl-benzimidazolyl-
benzothiazole (5) at 150 °C in 2N NaOH (6.4%), to lead to compound (6) 
with a 88% yield. In order to achieve a chain of ethylthioaryl groups, we 
reacted thioaryls with compound (6) by condensation. Thus, the action 
of thiophenol on 1-(2-chloroethyl)-2-thiomethyl-
benzimidazolybenzothiazole (6) in ethanol at reflux gave 1-
(ethylthiophenyl)-2-thiomethylbenzimidazolylbenzothiazole (7a) in 
62% yield. The action of 2-mercaptobenzimidazole and its analogues on 
1-(2-chloroethyl)-2-benzimidazolylbenzothiazole in refluxing ethanol 
gave 1-(ethylheteroaryl)-2-thiomethylbenzimidazolylbenzothiazole (7b-
d) in yields between 34 and 65% (Scheme 1). 
2-thiomethylbenzimidazolylbenzothiazole (5) 
In a round bottom flask, a mixture of 2-(chloromethyl)-1H-
benzimidazole (1.66 g) and 2-mercaptobenzothiazole (1.51 g) in THF 
(30 ml) is stirred in the presence of triethylamine (2 ml) for 6 h at room 
temperature. Then, THF is removed using a rotary evaporator and ice 
water (30 ml) is added to the reaction medium to get a precipipate solid. 
After filtration, the crude solid product is washed with water and 
purified on silica gel using a mixture of acetone and hexane: (4.25/0.75) 
as an eluent. Yield = 54%; Mp = 176-177 °C (hexane/ethyl acetate) 
NMR1H (DMSOd-6, δ ppm): 4,90 (2H, s, SCH2); 7,15-7,19 (2H, m, Har); 
7,34-7,59 (4H, m, H); 7,59-7,91 (1H, m, Har); 8,01-8,04 (1H, m, Har); 
NMR13C (DMSOd-6, δ ppm): 28,86 (S-CH2); 45,5 (CH2Cl); 60 (N-
CH2);121,56 (Car), 149,27 (CH2-C=N); 150,51 (N=C-S). SDM: m/e (%) = 
132,9 (61); 151 (69); 261,1 (25); 280 (7); 281 (100); 282,1 (20). 
1-(2-Chloroethyl)-2-thiomethylbenzimidazolylbenzothiazole (6) 
In a flask, 2g (1.1 mmol) of 2-thiomethylbenzimidazolyl-benzothiazole 
are dissolved in 40 ml of 2N sodium hydroxide solution (6.4%). The 
mixture is stirred for 30 min, then 5 ml of 1,2-dichloroethane and a 
pinch of tetrabutylammonium (TBA) are added. The mixture is heated 
at 150 °C for 1h. After cooling to room temperature, a 10% 
hydrochloric acid solution is added to the reaction medium to get a 
precipitate which is filtered under filter paper and dried. Yield: 88%; 
Mp = 132-133 °C, NMR 1H (DMSOd-6, δ ppm): 4,54 (2H, s, SCH2); 4,00 
(2H, t, CH2N); 3,26 (2H, t, CH2-S-Ar); 7,24-8,1 (m, Har). NMR13C 
(DMSOd-6, δ ppm): 28,86 (S-CH2); 45,5 (CH2Cl); 60 (N-CH2); 121,56 
(Car), 149,27 (CH2-C=N); 150,51 (N=C-S). 
1-(Ethylheteroaryl)-2-thiomethylbenzimidazolylbenzothiazole (7) 
In a 100 ml flask, 0.3g of 1-(2-chloroethyl)-2-
thiobenzimidazolylbenzothiazole is dissolved in 10 ml of ethanol 
solution. The mixture is stirred at room temperature for 30 min. 
Then 1.5 eq of 2-mercaptobenzimidazole or analogues are added. 
Then the reaction mixture is heated under reflux for 7h. The reaction 
mixture is cooled and neutralized with a 5% sodium hydrogen 
carbonate (NaHCO3) solution. The precipitate obtained is recovered 
by filtration on filter paper, washed with ethanol and dried.  
1-(2-Ethylthiophenyl)-2-thiomethylbenzimidazolyl-
benzothiazole (7a) 
Yield = 62%; Mp = 130-131 °C. NMR 1H (DMSOd-6, δ ppm): 4,54 (2H, 
s, SCH2); 4,00 (2H, t, CH2N); 3,26 (2H, t, CH2-S-Ar); 7,24-8,1 (m, Har). 
NMR13C (DMSOd-6, δ ppm): 28,86 (S-CH2); 34,3 (N-CH2); 51 (CH2-S-
Ar); 121,56 (Car), 149,27 (CH2-C=N); 150,51 (N=C-S). 
1-(ethylthiobenzimidazolyl)-2-thiomethylbenzimidazolyl 
benzothiazole (7b) 
Yield = 55%; Mp = 239-240 °C; NMR 1H (DMSOd-6, δ ppm): 4,54 (2H, 
s, CH2S); 3,40 (2H, t, CH2SAr); 4,15 (2H, t, CH2N); 7,21-8,10 (m, Har). 
NMR13C (DMSOd-6, δ ppm): 28,86 (S-CH2); 34,6 (N-CH2); 51 (CH2-S-
Ar); 121,56 (Car), 149,27 (CH2-C=N); 150,51 (N=C-S). 
1-(Ethylthiobenzothiazolyl)-2-thiomethylbenzimidazolyl-
benzothiazole (7c) 
Yield: 34%, Mp>260 ° NMR 1H (DMSOd-6, δ ppm): 4,54 (2H, s, 
CH2S); 3,76 (2H, t, CH2SAr); 4,15 (2H, t, CH2N); 7,21-8,10 (m, Har). 
RMN13C (DMSOd-6, δ ppm): 28,86 (S-CH2); 34,6 (N-CH2); 51 (CH2-S-
Ar); 121,56 (Car), 149,27 (CH2-C=N); 150,51 (N=C-S). 
1-(Ethylthiobenzoxazolyl)-2-thiomethylbenzimidazolyl-
benzothiazole (7d) 
Yield: 65%, Mp>260 °C, NMR 1H (DMSOd-6, δ ppm): 4,54 (2H, s, 
CH2S); 3,40 (2H, t, CH2SAr); 4,15 (2H, t, CH2N); 7,21-8,10 (m, Har). 
NMR13C (DMSOd-6, δ ppm): 28,86 (S-CH2); 34,6 (N-CH2); 51 (CH2-S-
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Scheme 1: Synthesis of 2-(2-((benzo[d]oxazol-2-ylthio)methyl)-1H-benzo[d]imidazol-1-yl)acetohydrazide derivatives 
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RESULTS AND DISCUSSION 
We have synthesized and characterized 6 derivatives of N-alkylated 
bis-benzimidazoles (5, 6 and 7a-d). These are listed in table 1 with 
their melting points, reaction yields and spectroscopic data. All 
compounds have in their respective molecule, the heterocycle 
benzimidazole and its analog benzothiazole as a basic molecule. 
Also, these molecules carry on the pyrrolic nitrogen of the 
benzimidazole nucleus a thioakylaryl linkage. The analysis of the 1H 
NMR spectrum for compound 5, base molecule, revealed the 
presence of a singlet δ = 4.90 ppm and this peak is attributed to the 
protons of the methylene group of 2-thiomethylbenzimidazolyl-
benzothiazole (5). As for the 13C spectrum, we noticed the presence 
of a signal at 28.86 ppm which characterized the carbon of the (S-
CH2) group. From compound 5, we proceeded to alkylation with 1,2-
dichloroethane [11], which allowed us to obtain compound 6. The 1H 
NMR analysis of 6 revealed the disappearance of the signal of the 
proton of the pyrrolic nitrogen initially around 12 ppm. Also, this 
analysis indicated the presence of two signals at 3.74 ppm and 4.60 
ppm which could be attributed to the two methylenes between 
nitrogen and sulfur (N-CH2-CH2-S). On its 13C NMR spectrum, we 
observed the remarkable presence of 2 major signals at 45 ppm and 
60 ppm which corresponded to the carbon peaks of the N-CH2-CH2-S 
group.  
Finally, the coupling reaction between compound 6 and the different 
mercaptobenzimidazoles and its analogues gave compounds 7a and 
7b-d. In addition to the remarkable peaks on these different 1H and 
13C NMR spectra, we noted the massive presence of protons around 
7 ppm which corresponded to the peaks of aromatic protons of the 
aryl and benzimidazole ring. On the 13C spectrum of compound 7, we 
had peaks between 115 and 165 ppm which were the aromatic 
peaks. All this information confirmed the synthesis of compounds 5, 
6, and 7a-d. 
 
Table 1: The physicochemical properties of synthesized bis-benzimidazole N-alkyl derivatives 
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benzothiazoles 7a-d were obtained by a four-step chemical reaction. 
The yield and purity of these compounds were found to be 
satisfactory. All these molecules are further aimed to screen suitable 
pharmacological properties, especially anthelmintic and antifungal. 
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